Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
Ultratech’s resolution plan for Binani Cement submitted at NCLT

2018-06-04 livemint
Kolkata: The resolution professional of Binani Cement Ltd. on Monday submitted the resolution plan of Ultratech Cement Ltd. at the Kolkata bench of the National Company Law Tribunal for its approval even as the tribunal agreed to hear Dalmia Bharat’s objections about Ultratech’s bid.
BINANIIND DALMIABHA 533309 UCLQY UCLQF 532538 500059 ULTRACEMCO

0
Binani Industries Limited - Outcome of Board Meeting

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BINANIIND 500059

1
Binani lenders okay UltraTech acquisition

2018-05-31 freepressjournal.in
New Delhi : The lenders of Binani Cement have issued letter of intent to UltraTech after approving its bid to acquire the company under the bankruptcy code, Aditya Birla group firm said on Wednesday. The Committee of Creditors (CoC) of Binani Cement on May 28 approved the resolution Plan submitted by UltraTech Cement, it said.
BINANIIND UCLQY UCLQF 532538 500059 ULTRACEMCO

1
Binani Cement lenders back UltraTech’s offer

2018-05-28 livemint
Mumbai: UltraTech Cement Ltd’s Rs7,950 crore bid to acquire Binani Cement Ltd has received near-unanimous backing from lenders to the distressed building material maker even as a legal battle reached the country’s top court, two people aware of the development said.
BINANIIND DALMIABHA 533309 UCLQY UCLQF 532538 PRMQY 500059 500302 ULTRACEMCO PEL

4
Binani Cement lenders vote in favour of UltraTech offer

2018-05-28 moneycontrol
The committee of creditors (CoC) for Binani Cement May 28 voted in favour of accepting UltraTech Cement’s Rs 7,950 crore bid.
BINANIIND 500116 DALMIABHA 533309 UCLQY IDBI UCLQF 532538 500059 ULTRACEMCO SBAZ

1
NCLAT refuses to stay Binani Cement insolvency proceedings

2018-05-22 livemint
New Delhi:The National Company Law Appellate Tribunal (NCLAT) on Tuesday refused to stay the corporate insolvency resolution process for Binani Cement Ltd.
BINANIIND UCLQY UCLQF 532538 500059 ULTRACEMCO

0
Binani Ind offers to repay 100% debt of cement unit

2018-05-17 freepressjournal.in
New Delhi : Binani Industries, which holds a 98.4 per cent stake in debt-ridden Binani Cement, on Wednesday offered to clear the 100 per cent claims of creditors at the National Company Law Appellate Tribunal.
BINANIIND 500059

1
Binani Industries offers to pay 100% debt amount of Binani Cement

2018-05-16 livemint
New Delhi: Binani Industries Ltd, the parent of debt-ridden Binani Cement Ltd, told the National Company Law Appellate Tribunal (NCLAT) on Wednesday that it was ready to pay up all the dues of its subsidiary to its financial and operational creditors in two weeks, if the tribunal so permitted.
BINANIIND DALMIABHA 533309 UCLQY UCLQF 532538 500059 ULTRACEMCO

0
Binani Industries Limited - Shareholders meeting

2018-05-15 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BINANIIND 500059

0
Binani Cement#39;s lenders call off meeting after Dalmia#39;s objection

2018-05-10 moneycontrol
A scheduled meeting of Binani Cement's lenders for Thursday has been postponed after Dalmia Bharat alleged that UltraTech is ineligible from participating in the auction.
BINANIIND DALMIABHA 533309 500059

3
Lenders fret as insolvency cases miss deadlines, hope delays yield better returns

2018-05-04 moneycontrol
The fate of a few of the 12 stressed accounts facing insolvency proceedings — including Essar Steel and Binani Cement — hangs in the balance as court cases are delaying the resolution process beyond the stipulated deadline of 270 days.
ESL BINANIIND KMBKY BHUSANSTL 533264 532538 UCLQF 513216 532778 ULTRACEMCO UTTAMSTL UCLQY KOTAKBANK 500059 500247 LITL 500055

1
It’s Dalmia vs UltraTech again for Binani Cement

2018-05-02 livemint
Kolkata: The Kolkata bench of the bankruptcy court on Wednesday ruled that the lenders of debt-ridden Binani Cement Ltd should consider the revised offer of UltraTech Cement Ltd even as it allowed Dalmia Bharat Ltd, chosen by lenders to take over the indebted cement-maker, to submit new bids, effectively restarting a contest between the two suitors.
BINANIIND DALMIABHA 533309 UCLQY UCLQF 532538 500059 ULTRACEMCO

0
Binani Industries Limited - Resignation

2018-04-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BINANIIND 500059

0
Binani Industries Limited - Appointment

2018-04-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BINANIIND 500059

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...